Growth hormone secretion in critical illness: effect of dopamine
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The catabolic state is a major contributor to the morbidity and mortality of critical illness. The underlying mechanism is poorly understood. We examined the endogenous secretion of an anabolic protein, GH, and studied the effect exerted on its secretion by dopamine, a catecholamine that is frequently administered for cardiovascular purposes in critical care. In a randomized controlled study of critically ill adult polytrauma patients (n = 11), we evaluated the effect of prolonged (83- to 296-h) dopamine infusion (5 micrograms/kg.min, iv) on the dynamics of GH secretion and on serum insulin-like growth factor-I, cortisol, and insulin concentrations. The effect of brief (15- to 21-h) dopamine administration was documented in an additional randomized controlled cross-over study involving nine patients. The GH profiles, obtained by blood sampling every 20 min for 9 h during 2 consecutive nights, were examined by deconvolution analysis. GH release was found to be exclusively pulsatile in all patients. Prolonged and brief dopamine infusions appeared to have similar effects. Twenty-four hours before initiation or after withdrawal of dopamine infusion, mean serum GH concentrations, mean secretion rate, amount of GH per secretory burst, and secretory burst amplitude were low, but, respectively, a median of 17% (P = 0.028), 36% (P = 0.046), 40% (P = 0.008), and 94% (P = 0.002) higher than those during dopamine infusion. After dopamine withdrawal, increased GH secretion was detectable within 3 h. Dopamine's effect on GH release was specific, as this agent had no discernable effect on the elevated serum cortisol and insulin concentrations or the low plasma insulin-like growth factor-I levels within 24 h. In conclusion, the present data suggest that pulsatile GH secretion is low during critical illness and that dopamine infusion further attenuates GH secretion through amplitude modulation, possibly as a result of a direct inhibitory action on the somatotropes. The latter iatrogenic effect might further aggravate the catabolic state of critical illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ross, R. J. M., Miell, J. P., Holly, J. M. P., Maheshwari, H., Norman, M., Abdulla, A. F., & Buchanan, C. R. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03549.x · Cited by 93
Cited by
Friedrich, J. O., Adhikari, N., Herridge, M. S., & Beyene, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00010 · Cited by 516
Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress
Dünser, M. W., & Hasibeder, W. R. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609340519 · Cited by 488
Veldhuis, J. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3209 · Cited by 389
Novel insights into the neuroendocrinology of critical illness
Van den Berghe, G. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430001 · Cited by 257
Vasopressor and inotropic support in septic shock: An evidence-based review
Beale, R. J., Hollenberg, S. M., Vincent, J.-L., & Parrillo, J. E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142909.86238.b1 · Cited by 260
Metadata
- Authors
- Van den Berghe, G.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-10-01
- Volume
- 79
- Issue
- 4
- Pages
- 1141-1146
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2135632964
- Cited by
- 101
- References
- 1
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth hormone secretion in critical illness: effect of dopamine. https://app.cochat.ai/papers/10.1210/jc.79.4.1141
- The paper
- Van den Berghe, G. (1994). Growth hormone secretion in critical illness: effect of dopamine. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.79.4.1141
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.